LIFEVANTAGE CORP Debt Conversion, Original Debt, Interest Rate of Debt
LIFEVANTAGE CORP (LFVN) reported Debt Conversion, Original Debt, Interest Rate of Debt of 8.00% for the 12-month period ending 2020-06-30, per its 10-K filed 2020-08-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtInterestRateOfDebt · last filed 2020-08-18
- LIFEVANTAGE CORP debt conversion, original debt, interest rate of debt for fiscal 2020 was 8.00%.
| Period end | Debt Conversion, Original Debt, Interest Rate of Debt 12 month |
|---|---|
| 2020-06-30 | 8.00% 10-K · filed 2020-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |